FDA Inspection
California Pharmacy & Compounding CenterCalifornia Pharmacy & Compounding Center – FDA Inspection, Dec 17, 2018
Record Details
This FDA Inspection record concerns California Pharmacy & Compounding Center, with an inspection on December 17, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Linda Thai (FDA Associated Person)
- Mariza M. Jafary (Issuing Officer)
View Company Profile
ID · 7659447c-6a79-4af3-86d9-7b2970b232b9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1074872
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Amended 483
FDA Citations
1- FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of California Pharmacy & Compounding Center
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 21, 2017 | Not classified | Los Angeles District Office | Drug Quality Assurance |
| August 31, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 17, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 25, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for California Pharmacy & Compounding Center
- FDA Inspection 1013560 - 2017-04-21
- FDA Inspection 986751 - 2016-08-31
- FDA Inspection 900112 - 2014-10-17
- FDA Inspection 893386 - 2014-08-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.